Open access · OA
via Europe PMC
Dementia, mood disorders, and aging: Bridging new avenues of care through shared biological pathways.
Aging advances · 2026 · ▲ 2 citations
Telomere attrition
Mitochondrial dysfunction
Cellular senescence
Disabled macroautophagy
Rapamycin / mTOR inhibition
Human
Abstract
With advancing age and lifespan throughout the globe in both developed and developing nations, the risk for developing cognitive loss and mood disorders increases significantly to the extent that after reaching the age of 65, this risk almost doubles every 5 years thereafter. As a result, a corresponding rise in non-communicable diseases will impact individuals with dementia and mood disorders involving Alzheimer's disease, multiple sclerosis, depression, and anxiety. On a clinical basis, multiple risk factors and presentations that involve the loss of intellectual capacity with the onset of mental health conditions, mood disorders preceding dementia, sleep fragmentation initiation, perivascular pathway disruptions, and circadian clock dysfunction can occur in both cognitive loss and mood disorders, but a much broader scope of shared underlying cellular pathways form the underpinning for the connection of these disorders that rests upon metabolic disorders, such as diabetes mellitus. Cognitive impairment and mood disorders can precede one another as well as coexist with related co-morbidities that involve metabolic disorders with diabetes mellitus, but present treatment strategies for these disorders are primarily symptomatic in nature and rely upon disease-altering therapies that may slow disease progression but also may be accompanied by disabling complications. Given these challenges, the institution of innovative avenues is critical at this juncture to address the mutual cellular mechanisms for the treatment of disorders involving Alzheimer's disease, multiple sclerosis, depression, and anxiety. The pathways of cell senescence(definition) and telomere(definition) biology with aging, cellular metabolic dysfunction, apolipoprotein E, oxidative stress, programmed cell death with autophagy(definition), ferroptosis, and pyroptosis, mechanistic target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition), glucagon-like peptide-1 receptor agonism, mammalian forkhead transcription factors of the "O" class, and mitochondrial dynamics offer a compelling potential to bridge these underlying pathways into unifying strategies for transition into efficacious clinical care for dementia and mood disorders. Tempered with this enthusiasm for these mutual disease mechanisms is the complexity of these pathways that will require meticulous oversight of the interdependence among pathway components and their ultimate biological impact on clinical outcomes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.4103/agingadv.agingadv-d-26-00011
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
K., M. (2026). Dementia, mood disorders, and aging: Bridging new avenues of care through shared biological pathways. <em>Aging advances</em>. https://doi.org/10.4103/agingadv.agingadv-d-26-00011
Vancouver
K. M. Dementia, mood disorders, and aging: Bridging new avenues of care through shared biological pathways. Aging advances. 2026. doi:10.4103/agingadv.agingadv-d-26-00011.
BibTeX
@article{maiese2026Dement,
title = {Dementia, mood disorders, and aging: Bridging new avenues of care through shared biological pathways.},
author = {Maiese K.},
journal = {Aging advances},
year = {2026},
doi = {10.4103/agingadv.agingadv-d-26-00011},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International review of neurobiology 2026
Citation only
Running out the clock: Circadian rhythm dysfunction in cognitive disease.
Expert review of clinical pharmacology 2026
Citation only
Osteoarthritis and dementia: contrasting disorders driven by mutual pathways of autophagy, mTOR, GLP-1, AMPK, Wnt, and WISP1.
Cells 2023
Open access · CC-BY
Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK
Antioxidants (Basel, Switzerland) 2026
Open access · OA
Chasing the FoxO in Metabolic Disorders: Novel Considerations for Oxidative Stress, Programmed Cell Death, Wnt, and the Gut Microbiome.
Scientific Reports 2018
Open access · CC-BY
Longevity extension in Drosophila through gut-brain communication
BMC biotechnology 2025
Open access · OA